CYTOCHROMA AGREEMENT means the Collaborative Research, Development and License Agreement between Allergan, Inc. and Cytochroma, Inc., dated May 31, 1999, as amended on June 25, 2001.
Sublicense Agreement means any agreement or arrangement pursuant to which Licensee (or an Affiliate or Sublicensee) grants to any third party any of the license rights granted to the Licensee under the Agreement.
Supply Agreement has the meaning set forth in Section 7.1.
License Agreement means the agreement between SAP (or an SAP SE Affiliate, or an authorized reseller) under which Customer procured the rights to use SAP Software or a Cloud Service.
Collaboration Agreement has the meaning set forth in the Recitals.
Manufacturing Agreement has the meaning set forth in Section 2.6.
End User License Agreement means a license grant or end user license agreement governing software as further described in this Agreement or any applicable Appendix.
IP License Agreement means the Intellectual Property License agreement set forth as Exhibit E hereto.
License Agreements shall have the meaning set forth in Section 8.11 hereof.
Software License Agreement means the Motorola Software License Agreement (Exhibit A).
Novartis shall have the meaning set forth in the Preamble.
Third Party Agreement has the meaning set forth in Section 6(a) hereof.
Supply Agreements has the meaning set forth in Section 7.1.
Clinical Supply Agreement shall have the meaning set forth in Section 7.2.
Technology License Agreement means the agreement in the form of Exhibit H hereto.
Collaborative agreement means a voluntary, written, or electronic arrangement between one
Commercial Supply Agreement has the meaning set forth in Section 4.1 (Supply Agreement).
Biomarker means a parameter or characteristic in a patient or Patient Sample, the measurement of which is useful (a) for purposes of selecting appropriate therapies or patient populations or monitoring disease susceptibility, severity or state, or monitoring therapies for such patient and/or (b) for predicting the outcome of a particular treatment of such patient.
Development Agreement has the meaning set forth in the Recitals.
Pharmacovigilance Agreement has the meaning set forth in Section 4.3.
Company License Agreements means any license agreements granting any right to use or practice any rights under any Intellectual Property (except for such agreements for off-the-shelf products that are generally available for less than $25,000), and any written settlements relating to any Intellectual Property, to which the Company is a party or otherwise bound; and the term “Software” means any and all computer programs, including any and all software implementations of algorithms, models and methodologies, whether in source code or object code.
Intercompany License Agreement means any cost sharing agreement, commission or royalty agreement, license or sublicense agreement, distribution agreement, services agreement, intellectual property rights transfer agreement, any related agreements or similar agreements, in each case where all parties to such agreement are one or more of the Issuer or a Restricted Subsidiary.
Research Agreement means a new written contract, grant or cooperative agreement entered into between a person and a college or research corporation for the performance of qualified research; however, all qualified research costs generating a rebate must be spent by the college or research corporation on qualified research undertaken according to a research agreement.